Hello Friends! Are you looking to invest in the stock market, or have you already invested? Would you like to know the predictions regarding the potential fluctuations in your shares? If so, you have landed on exactly the right page. On this page, you will find information regarding Biocon share price live, Biocon share price chart, Biocon share price history, Biocon News, Biocon share price prediction, Biocon share price screener, and much more. Furthermore, this page provides details on Biocon‘s share price targets 2026, 2027, 2028, 2029, 2030, 2040, and beyond.
Biocon Company Information
| Industry |
Biopharmaceutical Biotechnology |
| Founded | 1978 (48 years ago) |
| Founder |
Kiran Mazumdar-Shaw |
| Headquarters | Bengaluru, Karnataka, India |
| Key people | Kiran Mazumdar-Shaw (executive chairperson) Peter Bains (Group CEO) Siddharth Mittal (CEO & Managing Director) Shreehas P Tambe (CEO & Managing Director, Biocon Biologics Limited) |
Biocon Share Price Target Overview
- Current Price – 426.75
- Open – 433.00
- High – 433.20
- Low – 421.75
- Mkt cap – 69.11KCr
- P/E ratio – 151.33
- 52-wk high – 436.90
- 52-wk low – 327.60
- Dividend – 0.12%
- Qtrly div amt – 0.13
Biocon Share Price Chart
Biocon Share Price Target Tomorrow (Prediction)
| Biocon Share Price Target Years | Biocon Share Price Target |
| 2026 | ₹440 |
| 2027 | ₹550 |
| 2028 | ₹650 |
| 2029 | ₹750 |
| 2030 | ₹850 |
Biocon Share Price Target 2026
The target for Biocon’s share price in 2026 is projected to range between ₹430 and ₹440. As of mid of May 2026, Biocon’s share price stood at ₹426.75. Compared to the previous year, Biocon’s share price has witnessed an increase this year.
Biocon Share Price Target 2027
The target for Biocon’s share price in 2027 is projected to range between ₹540 and ₹550. On 22 May 2026, Biocon Share price NSE is 426.75 INR. Compared to last year, no significant difference has been observed in the share price of Biocon. The share price has increased by approximately 90-100 rupees.
Biocon Share Price Target 2030
The target for Biocon’s share price in 2030 is projected to range between ₹840 and ₹850. Over the past several years, the company has generated substantial profits, and investors, too, have earned handsome returns proportionate to their shareholdings. We remain optimistic that the company will continue to generate profits in the future, thereby ensuring continued returns for its investors.
Read Also:- Black Rose Industries Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
Biocon Shareholding Pattern
| Promoter | 44.91% |
| FII | 13.20% |
| DII | 7.54% |
| Retails & Others | 17.82% |
| Mutual Funds | 16.53% |
Income Statement Of Biocon
|
All values in INR
|
Jun 2025
|
Sep 2025
|
Dec 2025
|
Mar 2026
|
|---|---|---|---|---|
|
Revenue
|
39.42B
|
42.96B
|
41.73B
|
45.17B
|
|
Cost of goods sold
|
14.05B
|
17.72B
|
13.39B
|
13.99B
|
|
Cost of revenue
|
14.05B
|
17.72B
|
13.39B
|
13.99B
|
|
Research and development expenses
|
-346.00M
|
-132.00M
|
-531.00M
|
-128.00M
|
|
Total research and development expenses
|
–
|
–
|
–
|
–
|
|
Selling, general, and admin expenses
|
8.33B
|
9.59B
|
8.75B
|
9.12B
|
|
Operating expense
|
22.43B
|
21.18B
|
25.16B
|
26.10B
|
|
Total operating expenses
|
36.48B
|
38.90B
|
38.55B
|
40.10B
|
|
Operating income
|
2.94B
|
4.05B
|
3.18B
|
5.07B
|
|
Other non operating income
|
-11.62B
|
94.00M
|
1.17B
|
525.00M
|
|
EBT including unusual items
|
969.00M
|
1.71B
|
-678.00M
|
2.48B
|
|
EBT excluding unusual items
|
-11.45B
|
1.23B
|
2.26B
|
3.28B
|
|
Income tax expense
|
77.00M
|
385.00M
|
-160.00M
|
489.00M
|
|
Effective tax rate
|
7.95%
|
22.48%
|
23.60%
|
19.76%
|
|
Other operating expenses
|
9.89B
|
6.72B
|
11.78B
|
11.98B
|
|
Net income
|
314.00M
|
845.00M
|
1.44B
|
1.26B
|
|
Net profit margin
|
0.80%
|
1.97%
|
3.45%
|
2.79%
|
|
Earnings per share
|
0.26
|
0.72
|
2.74
|
1.27
|
|
Interest and investment income
|
–
|
235.00M
|
–
|
–
|
|
Interest expense
|
-2.77B
|
-2.72B
|
-2.10B
|
-2.32B
|
|
Net interest expenses
|
-2.77B
|
-2.49B
|
-2.10B
|
-2.32B
|
|
Depreciation and amortization charges
|
4.55B
|
4.73B
|
5.15B
|
5.13B
|
|
EBITDA
|
6.89B
|
8.69B
|
7.13B
|
9.96B
|
|
Gain or loss from assets sale
|
–
|
–
|
–
|
–
|
Read Also:- Gem Aromatics Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
Hi, I’m Ronak, a news writer covering the latest updates in automobiles, education, smartphones, and trending topics. I focus on delivering simple, clear, and timely news to keep readers informed about what’s happening around the world.